Home
About
Help
Alert
Account
Login
Create
Advertisement
Advertisement
Back to Search Results
Search
Advanced
Search
Find article
Advanced search
Chelation therapy with deferasirox versus deferoxamine in transfusion-dependent sickle-cell disease: a cost-effectiveness analysis from the US perspective
Delea T
;
Sofrygin O
;
Baladi J
;
Thomas SK
;
Coates TD
Policy Analysis Inc. (PAI), Four Davis Court, Brookline, MA 02445 USA. tdelea@pai2.com
Haematologica. 2006;91((Suppl 1):): Abstract No. 0003.
Study details
Study Design :
Economic Study